In addition, several investigations on TFAP2E have shown a tumor suppressive influence, and decreased expression levels indicate promoted oncogenesis, stemness and chemoresistance in several types of cancers, including colorectal cancer, gastric cancer, neuroblastoma and skin neoplasia [10, 144–146]. This evidence concerns the gene TFAP2E and neoplasm.